The theme for the 2018 Annual Meeting of the American Society of Clinical Oncology is “Delivering Discoveries: Expanding the Reach of Precision Medicine.” For St. Jude Children’s Research Hospital, investigators present data on how St. Jude embraces the precision medicine model for treating and researching childhood cancer. CAR T-cell therapy, childhood cancer survivorship research and a number of clinical precision medicine applications are among the topics St. Jude researchers will discuss at the five-day meeting that begins Friday, June 1, in Chicago.
Select Onsite Experts
When: Monday, June 4 at 11:50 a.m. CST
Title: The Landscape of CAR T Beyond ALL
Stephen Gottschalk, MD, Chair of the St. Jude Department of Bone Marrow Transplantation & Cellular Therapy, along with experts from Children’s Hospital Colorado and Nationwide Children’s, will share advances in immunotherapy for solid tumors in pediatric oncology.
When: Tuesday, June 5 at 8:20 a.m. CST
Title: Addressing the Unique Cognitive Needs of Pediatric and AYA Cancer Survivors
Pediatric Oncology Posters
When: Saturday, June 2 at 8-11:30 a.m.
Location: Hall A
|10548: Outcomes for young children with molecularly defined ependymoma treated on the multi-institutional SJYC07 clinical trial.
|Santhosh Upadhyaya, MBBS, MD (presenter)|
|10565: Exercise intolerance among survivors of childhood cancer exposed to cardiotoxic therapy: Identification of survivors at increased risk through myocardial strain and ejection fraction.
|Kirsten K. Ness, PhD (presenter)|
|10566: Long-term renal function after treatment for Wilms tumor. A report from the St. Jude Lifetime Cohort (SJLIFE) study.
|Daniel M. Green, MD (presenter)|
|10567: Racial/ethnic differences in neurocognitive, emotional and quality of life outcomes in adult survivors of childhood cancer: A report from the Childhood Cancer Survivor Study (CCSS).
|Stephanie Dixon, MD (presenter)|
|10570: Neurologic morbidities, psychological distress, and functional independence in adult survivors of childhood cancer treated with CNS-directed therapies: A report from the Childhood Cancer Survivor Study
|Stefanie C. Vuotto, PhD (presenter)|
|10571: Longitudinal assessment of patient-reported cumulative symptom burden as an indicator of chronic health conditions in adult survivors of childhood cancer: A joint report of the St. Jude Lifetime Cohort (SJLIFE) and the Childhood Cancer Survivor Study (CCSS).
|I-Chan Huang, PhD (presenter)|
|10573: Comprehensive molecular characterization of pediatric treatment-induced glioblastoma: Germline DNA repair defects as a potential etiology
|John Thomas Lucas, MD (presenter)|
Patient and Survivor Care Posters
When: Monday, June 4 at 1:15-4:45 p.m.
Location: Hall A
|10078: Cumulative burden of severe chronic health conditions (CHC) and health related quality of life (HRQoL) among adult survivors of childhood cancer: A report from the St. Jude Lifetime Cohort study (SJLIFE).